Rensheng Wang
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 14
- Angiogenesis and VEGF in Cancer 7
-
- Head and Neck Cancer Studies 39
- Co-authors
- Min Kang (35 shared papers)Kai Hu (22 shared papers)Yong Zhang (14 shared papers)Fang Wu (12 shared papers)Meilian Liu (13 shared papers)Guisheng Li (8 shared papers)Wenqi Liu (9 shared papers)Jinxian Zhu (11 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Frontiers in Oncology (9 papers)Medicine (5 papers)Dose-Response (5 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesSouth Sudan
In The Last Decade
Rensheng Wang
129 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 128
- Otorhinolaryngology 340
- Cancer Research 405
- Molecular Biology 660
- Oncology 229
- Pulmonary and Respiratory Medicine 252
Countries citing papers authored by Rensheng Wang
This map shows the geographic impact of Rensheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rensheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rensheng Wang more than expected).
Fields of papers citing papers by Rensheng Wang
This network shows the impact of papers produced by Rensheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rensheng Wang. The network helps show where Rensheng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Rensheng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 111 | |
| 2 | 2020 | 77 | |
| 3 | 2022 | 77 | |
| 4 | 2013 | 68 | |
| 5 | 2017 | 48 | |
| 6 | 2012 | 46 | |
| 7 | 2022 | 42 | |
| 8 | 2018 | 41 | |
| 9 | 2019 | 39 | |
| 10 | 2016 | 38 | |
| 11 | 2019 | 33 | |
| 12 | 2013 | 30 | |
| 13 | Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial. | 2016 | 29 |
| 14 | 2019 | 25 | |
| 15 | Sp1 is over-expressed in nasopharyngeal cancer and is a poor prognostic indicator for patients receiving radiotherapy. | 2015 | 25 |
| 16 | 2023 | 24 | |
| 17 | 2019 | 24 | |
| 18 | 2012 | 24 | |
| 19 | 2016 | 23 | |
| 20 | 2013 | 23 |
About Rensheng Wang
Rensheng Wang is a scholar working on Molecular Biology, Otorhinolaryngology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 142 papers that have together received 1.7k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (39 papers), Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (14 papers), Lung Cancer Research Studies (11 papers), MicroRNA in disease regulation (8 papers), Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Advanced Surface Polishing Techniques (5 papers). The work is most often cited by research in Otorhinolaryngology (340 citations), Cancer Research (405 citations), Molecular Biology (660 citations), Oncology (229 citations) and Pulmonary and Respiratory Medicine (252 citations). Rensheng Wang has collaborated with scholars based in China, United States and South Sudan. Frequent co-authors include Min Kang, Kai Hu, Yong Zhang, Fang Wu, Meilian Liu, Guisheng Li, Wenqi Liu, Jinxian Zhu, Haolin Yan and Guosheng Feng. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Medicine, Dose-Response and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.